XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Series C Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series C Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series B Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series A Preferred Stock [Member]
Common Stock Outstanding [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2019             3,879,608       (43,658)    
Balance at Dec. 31, 2019             $ 13,898,494 $ 3,587,287 $ (9,992,841) $ (5,348,812) $ (160,784) $ (856,837) $ 1,126,507
Convertible Preferred Stock Issuance - cash (in shares)         362,660     140,000          
Convertible Preferred Stock Issuance - cash         $ 3,509,933     $ 116,667 3,626,600
Convertible Preferred Stock Issuance - conversion of debt (in shares)         48,200              
Convertible Preferred Stock Issuance - conversion of debt         $ 478,017     478,017
Common stock issued for placement agent fees (in shares)             200,000          
Common stock issued for placement agent fees         $ (306,000)     $ 306,000
Warrants issued to placement agent and other issuance costs         (752,924)       752,927
Placement agent fees and issuance costs         (820,160)       (820,160)
Beneficial Conversion feature (BCF) on Preferred Stock         (2,328,473)     2,328,473  
Deemed Dividend on BCF of Preferred Stock         2,328,473     (2,328,473)  
Accrued Deemed Dividend         52,741     (52,741)  
Net Loss               (638,696)   (638,696)
Net Loss               (638,696)   (638,696)
Less: Net (loss) income attributable to noncontrolling interest                             144,577 144,577
Net loss                               (494,119)
Foreign Currency Translation               (1,363,503) (1,363,503)
Deemed Dividend on BCF of Series C Preferred Stock         $ 2,328,473     (2,328,473)  
Balance (in shares) at Mar. 31, 2020         410,860     4,219,608       (43,658)    
Balance at Mar. 31, 2020         $ 2,161,607     $ 14,321,161 4,287,473 (10,631,537) (6,712,315) $ (160,784) (712,260) 2,553,342
Balance (in shares) at Dec. 31, 2019             3,879,608       (43,658)    
Balance at Dec. 31, 2019             $ 13,898,494 3,587,287 (9,992,841) (5,348,812) $ (160,784) (856,837) $ 1,126,507
Common stock issued for warrants exercised - cashless (in shares)                               391,308
Balance (in shares) at Dec. 31, 2020             500,000     5,827,304       (43,658)    
Balance at Dec. 31, 2020             $ 2,754,583     $ 14,537,828 5,041,511 (14,382,327) (5,885,112) $ (160,784) (718,212) $ 1,187,487
Convertible Preferred Stock Issuance - cash (in shares) 170,000     170,000                        
Convertible Preferred Stock Issuance - cash $ 1,500,000   $ 1,500,000 $ 1,612,707   $ 1,612,707     $ 1,000,000              
Deemed Dividend on BCF of Preferred Stock                     (1,500,000)         (1,500,000)
Accrued Deemed Dividend $ 28,333 $ (28,333)     $ (33,611) $ (33,611) $ 100,000 $ (100,000)                
Net Loss                       (422,163)       (422,163)
Net Loss                       (422,163)       (422,163)
Less: Net (loss) income attributable to noncontrolling interest                             41,814 41,814
Net loss                               (380,349)
Foreign Currency Translation                         (16,267)     (16,267)
Common stock issued for warrants exercised - cashless (in shares)                   103,104            
BCF on Series C Preferred Stock     $ 1,500,000               1,500,000         1,500,000
Deemed Dividend on BCF of Series C Preferred Stock                     (1,500,000)         (1,500,000)
Accretion of Series B Preferred Stock                     (46,932)         (46,932)
Balance (in shares) at Mar. 31, 2021 170,000     170,000     500,000     5,930,408       (43,658)    
Balance at Mar. 31, 2021 $ 1,528,333     $ 1,612,707     $ 2,854,583     $ 14,537,828 $ 4,832,635 $ (14,804,490) $ (5,901,379) $ (160,784) $ (676,398) $ 3,823,035